HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Twin transfusion syndrome: successful in utero treatment with digoxin.

Abstract
A pregnancy complicated by twin transfusion syndrome is presented. When signs of cardiac failure (edema, ascites and hydramnios) persisted in the recipient twin, maternal digoxin therapy was instituted at 27 weeks' gestation. The signs of failure resolved, and the twins were delivered electively by cesarean section at 34 weeks. At birth, the syndrome was confirmed by examination of the infants and placenta. Both infants survived. Digoxin therapy is recommended for fetal heart failure from circulatory overload in twin transfusion.
AuthorsJ De Lia, M G Emery, S A Sheafor, T A Jennison
JournalInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (Int J Gynaecol Obstet) Vol. 23 Issue 3 Pg. 197-201 (Jun 1985) ISSN: 0020-7292 [Print] United States
PMID2865181 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Digoxin
Topics
  • Adult
  • Cesarean Section
  • Digoxin (therapeutic use)
  • Female
  • Fetofetal Transfusion (diagnosis, drug therapy)
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Pregnancy
  • Prenatal Diagnosis
  • Twins
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: